Haijun

Haijun Ma is an accomplished professional in the field of biostatistics with extensive experience in leadership roles. Currently serving as Executive Director of Biostatistics at Exelixis since June 2022, Haijun previously held the position of Executive Director of Biostatistics, Safety, and Real-World Evidence at Nektar Therapeutics from September 2019 to June 2022. Prior experience at Amgen includes roles as Director of Biostatistics, Senior Biostatistics Manager, and Biostatistics Manager from August 2006 to September 2019. Haijun began a career in biostatistics with a summer internship at Eli Lilly in 2005. Educational achievements include a Ph.D. in Biostatistics from the University of Minnesota, a Master’s degree in Statistics from Iowa State University, and a Bachelor’s degree in Spanish from Nanjing University.